GENFIT’s mission is to discover and develop innovative medicines for the prevention and treatment of cardiometabolic disease. GENFIT is focused on bringing therapeutic and diagnostic solutions to the pharmaceutical industry to combat the major health concerns of diabetes, its associated risk factors, and its complications.
OUR VISION: DEVELOPING TOMORROW’S MEDICINES
GENFIT nurtures innovative drug research in an advanced scientific environment, with clinical output as the key permanent objective. GENFIT's vision is guided by four deeply-rooted principles:
- Focusing on patients needs: At GENFIT, our scientists know that the only objective is scientific discovery leading to improved patient care,
- Staying at the edge of innovation: We ensure constant leadership in our major fields of expertise, i.e. therapeutic innovation in cardiometabolic disease, transcription-based drug discovery approaches, and all technological developments related to our research efforts,
- Valuing partnerships: We recognise that pharmaceutical research and development need multiple types of expertise and resources. Our company culture values collaborations with world-class academic groups and leading international pharmaceutical teams. We recognise the importance of working together for common growth,
- Driving sound company governance and funding: We have a unique track-record of sound investment and financial management, and will continue to select the best corporate strategies to advance our objectives.
